BELLETTI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.158
EU - Europa 6.002
AS - Asia 4.906
SA - Sud America 653
AF - Africa 125
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 12
Totale 23.877
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.988
GB - Regno Unito 1.948
IT - Italia 1.900
CN - Cina 1.318
SG - Singapore 1.266
HK - Hong Kong 640
VN - Vietnam 505
BR - Brasile 477
SE - Svezia 438
DE - Germania 342
TR - Turchia 275
UA - Ucraina 240
FI - Finlandia 232
RU - Federazione Russa 224
FR - Francia 216
IN - India 172
KR - Corea 166
BD - Bangladesh 160
BG - Bulgaria 88
CA - Canada 77
NL - Olanda 73
AR - Argentina 62
MX - Messico 51
IQ - Iraq 50
JP - Giappone 50
IE - Irlanda 49
ID - Indonesia 46
ES - Italia 39
PK - Pakistan 36
PL - Polonia 34
IR - Iran 33
ZA - Sudafrica 33
CO - Colombia 29
BE - Belgio 28
RO - Romania 28
AE - Emirati Arabi Uniti 26
EC - Ecuador 21
CH - Svizzera 17
EG - Egitto 17
IL - Israele 17
CL - Cile 16
LT - Lituania 16
UZ - Uzbekistan 16
AU - Australia 15
DZ - Algeria 15
MY - Malesia 15
VE - Venezuela 15
MA - Marocco 14
SA - Arabia Saudita 14
GR - Grecia 13
CZ - Repubblica Ceca 12
JO - Giordania 12
PY - Paraguay 12
PT - Portogallo 11
KE - Kenya 10
KZ - Kazakistan 10
TN - Tunisia 10
TW - Taiwan 10
EU - Europa 9
PH - Filippine 9
AZ - Azerbaigian 8
RS - Serbia 8
AT - Austria 7
CR - Costa Rica 7
HU - Ungheria 7
JM - Giamaica 7
PE - Perù 7
UY - Uruguay 7
BO - Bolivia 6
DK - Danimarca 6
NP - Nepal 6
NZ - Nuova Zelanda 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
KH - Cambogia 5
NO - Norvegia 5
OM - Oman 5
PR - Porto Rico 5
AL - Albania 4
BZ - Belize 4
EE - Estonia 4
HN - Honduras 4
LK - Sri Lanka 4
NG - Nigeria 4
SN - Senegal 4
TH - Thailandia 4
AM - Armenia 3
BY - Bielorussia 3
CY - Cipro 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
YE - Yemen 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CG - Congo 2
GH - Ghana 2
Totale 23.847
Salva come PNG Salva come JPEG
Città #
Southend 1.526
Ashburn 1.176
Fairfield 1.079
Santa Clara 1.018
Singapore 781
Woodbridge 706
Chandler 649
Hong Kong 632
Houston 462
Jacksonville 457
Seattle 445
Wilmington 444
Chicago 420
Dearborn 387
Ann Arbor 379
Cambridge 369
Beijing 333
Hefei 331
San Jose 328
Nyköping 282
Los Angeles 243
Modena 236
London 229
Council Bluffs 176
Ho Chi Minh City 176
Izmir 158
Helsinki 146
The Dalles 131
New York 127
Milan 125
Seoul 121
Salt Lake City 99
Hanoi 92
Princeton 91
Rome 84
San Diego 83
Sofia 83
Eugene 80
Dallas 65
Lauterbourg 62
Moscow 58
Bologna 56
Buffalo 56
Redwood City 53
Fremont 48
Elk Grove Village 47
Falls Church 47
São Paulo 46
Shanghai 45
Tampa 44
Orem 42
Tokyo 42
Chennai 38
Munich 36
Phoenix 36
Bremen 35
Dublin 35
Frankfurt am Main 34
Columbus 32
Jakarta 28
Como 27
Napoli 26
Naples 25
Brussels 24
Des Moines 24
Guangzhou 24
Reggio Emilia 23
Florence 22
Lancaster 22
San Giuliano Milanese 22
Da Nang 21
Palermo 21
Tulare 21
Mexico City 18
Sterling 18
Warsaw 18
Baghdad 17
Boardman 17
Manchester 17
Brooklyn 16
Genoa 16
Johannesburg 16
Miami 16
Montreal 16
Norwalk 16
Stockholm 16
Bari 15
Catania 15
Kocaeli 15
Nanjing 15
New Delhi 15
Toronto 15
Perugia 14
Atlanta 13
Biên Hòa 13
Boston 13
Cairo 13
Dulles 13
Haiphong 13
Miano 13
Totale 16.383
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 583
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 506
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 475
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 435
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 431
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 420
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 416
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 414
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 395
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 395
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 394
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 393
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 392
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 366
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 363
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 362
Nanomedicine: the future for advancing medicine and neuroscience 358
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 357
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 357
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 355
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 352
Protein corona and nanoparticles: How can we investigate on? 351
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 347
Nanoparticle transport across the blood brain barrier 343
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 341
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 340
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 336
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 332
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 331
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 330
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 330
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 329
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 326
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 323
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 312
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 311
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 309
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 308
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 306
Functionalization of liposomes: microscopical methods for preformulative screening 304
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 304
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 296
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 295
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 293
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 271
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 266
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 262
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 259
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 254
Immunonanosystems to CNS pathologies: State of the art 252
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 252
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 251
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 251
Nanotechnology and Central Nervous System Drug Delivery 244
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 243
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 242
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 242
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 240
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 239
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 237
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 234
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE 229
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 229
Cholesterol nanoparticles partially rescue the alterations in synaptic phenotype of the R6/2 mouse model of Huntington's Disease 223
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 220
Leptin-conjugated nanoparticles as drug delivery system to the brain 216
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 215
TERAPIA NUTRIZIONALE PARENTERALE: APPROCCIO MULTIDISCIPLINARE, ORGANIZZATIVO E TECNOLOGICO 214
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 211
Ligand- based strategies to modified NPs surface for blood-brain barrier crossing 197
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 191
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 187
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 179
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 175
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 175
Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics (2016) 511 (1) (331-340) (S0378517316306512) (10.1016/j.ijpharm.2016.07.022)) 165
Nanomedicine in neurodegenerative disorders: Understanding the journey 152
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 141
Nanotechnology in medicine: therapeutic strategies in neurological disorders 140
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 130
Totale 24.084
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 0 0 0 0 0 0 0 0 96
2021/20221.693 100 156 169 79 55 102 103 112 190 145 277 205
2022/20231.840 201 225 155 182 201 240 55 186 206 29 75 85
2023/20241.333 72 66 91 98 298 139 145 172 37 39 59 117
2024/20253.723 170 54 62 287 765 520 279 307 335 161 354 429
2025/20266.889 436 214 456 876 1.382 473 738 330 698 731 444 111
Totale 24.084